from the desk of Dr. Terry F Allen

Skip navigation

Member Login  |  Contact Us  |  Sign Up

802-877-8330

Terry's Tips Stock Options Trading Blog

Netflix (NFLX) Shows Renewed Upward Momentum

January 27th, 2020

Netflix, a recent addition to the IBD Top 50 list, has shown strong bullish momentum despite a brief dip following its recent earnings report. The following article highlights some of the positive takeaways from the earnings report

L3 Harris Technologies (LHX) Breaks to Record Highs, What’s Next?

January 20th, 2020

LHX has received positive media coverage as of late. The IBD recently wrote an article naming the company its stock of the day and it has since rallied to trigger IBD’s buy point. Meanwhile, Zack’s has included the stock as part of their list of 4 defense stocks they think will do really well in 2020.

Copart (CPRT) Eyes $100 Price Point

January 13th, 2020

Copart is a momentum stock that has caught the eyes of many analysts, here are two of them – Why Copart (CPRT) Stock Might be a Great Pick and Why Do 123 A+ Funds Have A Stake In This Breakout IBD 50 Stock?

Salesforce.com (CRM) Shows Renewed Upward Momentum

January 6th, 2020

Salesforce.com is an outperformer and its stock is poised for an upside breakout. Take a look at the following two articles for details – Has salesforce.com (CRM) Outpaced Other Computer and Technology Stocks This Year? and Salesforce.com Is Ready for an Upside Breakout.

ServiceNow (NOW) Eyes All-Time Highs

December 30th, 2019

ServiceNow (NOW) is up 35% from its low two months ago and several analysts expect the stock to continue higher. Here are two of them

Visa (V) – A Steady Performer Poised for Gains

December 23rd, 2019

Visa is a popular stock among analysts. So much so that Kiplinger included it in their top 20 stocks to buy for 2020. Morgan Stanley likes the stock as well, check out the following article that discusses a price target upgrade – Morgan Stanley lifts Visa, Mastercard price targets.

Green Lights are Flashing for Merck & Co (MRK)

December 16th, 2019

Merck has been in the spotlight because of a recent acquisition and as several biotech’s have produced outsized gains as of late. The following two articles discuss the acquisition and how MRK is a better option compared to one of its peers – Merck: Adding To The Pipeline and Better Buy: Eli Lilly vs. Merck.

Jazz Pharmaceuticals (JAZZ) – A Pharma Stock on a Tear

December 9th, 2019

Recent media coverage suggests Jazz Pharmaceuticals is a stock that investors certainly want to own. Check out what these two articles have to say about it – Hedge Funds Got Back Into Jazz Pharmaceuticals plc and Two stocks I’d tuck away forever: Jazz Pharmaceuticals plc (JAZZ), HollyFrontier Corporation (HFC).

MOMO Inc. (MOMO) – A Growth Stock That Offers Value

December 2nd, 2019

Momo Inc. has been getting positive media coverage as of late, check out what these two analysts had to say about the stock – 3 Undervalued Mid-Cap Stocks That Score a “Perfect 10” and Better Buy: Momo vs. Huya.

J2 Global (JCOM) – A Little-Known Stock Showing a lot of Strength

November 25th, 2019

JCOM has broken higher from a major technical pattern. The weekly chart below shows that the roughly $91 price point offered a major hurdle since the stock price first approached it in early 2017.

Making 36%

Making 36% — A Duffer's Guide to Breaking Par in the Market Every Year in Good Years and Bad

This book may not improve your golf game, but it might change your financial situation so that you will have more time for the greens and fairways (and sometimes the woods).

Learn why Dr. Allen believes that the 10K Strategy is less risky than owning stocks or mutual funds, and why it is especially appropriate for your IRA.

Order Now

Success Stories

I have been trading the equity markets with many different strategies for over 40 years. Terry Allen's strategies have been the most consistent money makers for me. I used them during the 2008 melt-down, to earn over 50% annualized return, while all my neighbors were crying about their losses.

~ John Collins